Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 9,500 | |||
5 mg | 在庫あり | ¥ 22,500 | |||
10 mg | 在庫あり | ¥ 35,500 | |||
25 mg | 在庫あり | ¥ 68,000 | |||
50 mg | 在庫あり | ¥ 125,500 | |||
100 mg | 在庫あり | ¥ 181,000 | |||
500 mg | 在庫あり | ¥ 374,000 |
説明 | CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor. |
ターゲット&IC50 | PI3Kα:6.8 nM |
分子量 | 573.71 |
分子式 | C30H35N7O3S |
CAS No. | 1276105-89-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.73 mg/mL (9.99 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CNX-1351 1276105-89-5 PI3K/Akt/mTOR signaling PI3K CNX 1351 inhibit Phosphoinositide 3-kinase CNX1351 Inhibitor inhibitor